APA (7th ed.) Citation

Vijenthira, A., Maganti, M., Kukreti, V., Kuruvilla, J., Tiedemann, R., Chen, C., . . . Prica, A. (2019). Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naïve patients. Leukemia & Lymphoma, 60(10), 2576. https://doi.org/10.1080/10428194.2019.1585837

Chicago Style (17th ed.) Citation

Vijenthira, Abi, Manjula Maganti, Vishal Kukreti, John Kuruvilla, Rodger Tiedemann, Christine Chen, Michael Crump, and Anca Prica. "Outcomes of Patients with Relapsed Low-grade Lymphoma Retreated with Rituximab Are Similar to Rituximab Naïve Patients." Leukemia & Lymphoma 60, no. 10 (2019): 2576. https://doi.org/10.1080/10428194.2019.1585837.

MLA (9th ed.) Citation

Vijenthira, Abi, et al. "Outcomes of Patients with Relapsed Low-grade Lymphoma Retreated with Rituximab Are Similar to Rituximab Naïve Patients." Leukemia & Lymphoma, vol. 60, no. 10, 2019, p. 2576, https://doi.org/10.1080/10428194.2019.1585837.